These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Razmy A, Lang AE, Shapiro CM. Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626 [Abstract] [Full Text] [Related]
9. Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Manni R, Terzaghi M, Sartori I, Mancini F, Pacchetti C. Sleep Med; 2004 Mar; 5(2):189-93. PubMed ID: 15033142 [Abstract] [Full Text] [Related]
10. The range and nature of sleep dysfunction in untreated Parkinson's disease (PD). A comparative controlled clinical study using the Parkinson's disease sleep scale and selective polysomnography. Dhawan V, Dhoat S, Williams AJ, Dimarco A, Pal S, Forbes A, Tobías A, Martinez-Martin P, Chaudhuri KR. J Neurol Sci; 2006 Oct 25; 248(1-2):158-62. PubMed ID: 16780888 [Abstract] [Full Text] [Related]
12. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR. J Neural Transm (Vienna); 2001 Oct 25; 108(1):71-7. PubMed ID: 11261748 [Abstract] [Full Text] [Related]
13. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G. Mov Disord; 2002 Sep 25; 17(5):1026-30. PubMed ID: 12360553 [Abstract] [Full Text] [Related]
14. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Möller JC, Stiasny K, Hargutt V, Cassel W, Tietze H, Peter JH, Krüger HP, Oertel WH. Mov Disord; 2002 May 25; 17(3):474-81. PubMed ID: 12112193 [Abstract] [Full Text] [Related]
15. Excessive daytime sleepiness in parkinsonism. Arnulf I. Sleep Med Rev; 2005 Jun 25; 9(3):185-200. PubMed ID: 15893249 [Abstract] [Full Text] [Related]
17. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O. Eur J Neurol; 2005 Mar 25; 12(3):199-207. PubMed ID: 15693809 [Abstract] [Full Text] [Related]
18. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. Kallweit U, Siccoli MM, Poryazova R, Werth E, Bassetti CL. Eur Neurol; 2009 Mar 25; 62(3):176-9. PubMed ID: 19602890 [Abstract] [Full Text] [Related]
19. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease. Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu. Arch Neurol; 2009 May 25; 66(5):563-70. PubMed ID: 19433655 [Abstract] [Full Text] [Related]
20. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists. Del Dotto P, Gambaccini G, Caneparo D, Berti C, Bernardini S, Bonuccelli U. Neurol Sci; 2003 Oct 25; 24(3):170-1. PubMed ID: 14598071 [Abstract] [Full Text] [Related] Page: [Next] [New Search]